Award for Dr. Moloney for Fuchs endothelial dystrophy
in Clinical Trials, News, Ocular Surface Disease
25 Aug 2018
Dr Moloney and team investigated a surgical technique for Fuchs endothelial dystrophy. Fuchs endothelial dystrophy is a type of corneal disease that affects 1 in 25 people over the age of 40. The condition tends to affect women more than men.
Dr Moloney is a Clinical Senior Lecturer with our Discipline of Ophthalmology.
The treatment by Dr Moloney and his team involves targeted removal of problem areas of the eye. The surgeon strips cells from the eye’s central endothelium, a treatment which aims to reduce the need to rely on corneal transplants. A reduced need for transplants reduces the risk of organ rejection. That’s much better for patients. Also, corneal donations are in short supply.
After treatment, the cornea often regenerates with clearer, healthy tissue. However, more work needs to happen to improve treatment success rates.
For this work, Dr Greg Moloney received the prestigious Troutman Corneal Prize. The Cornea Society makes this award once a year. The award goes to the most innovative paper published by a young investigator.
You can see his paper here: